Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
Sponsor: Camurus AB
Summary
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Official title: A Multi-Center, Multinational, Observational Study of Octreotide Subcutaneous Depot for the Treatment of Patients With Acromegaly
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-06-05
Completion Date
2029-06
Last Updated
2026-06-30
Healthy Volunteers
No
Conditions
Interventions
Octreotide subcutaneous depot
Commercially available octreotide subcutaneous depot treatment administered by participants for a maximum duration up to 2 years in the study
Locations (5)
Universitaetsklinikum Aachen
Aachen, Germany
Universitaetsklinikum Leipzig
Leipzig, Germany
Fachpraxis für Innere Medizin, Endokrinologie und Diabetologie
Magdeburg, Germany
Medicover Neuroendokrinologie MVZ
München, Germany
Universitätsklinikum Würzburg
Würzburg, Germany